Recent

% | $
Quotes you view appear here for quick access.

Nymox Pharmaceutical Corporation Message Board

  • mghmd mghmd Jan 28, 2014 6:16 PM Flag

    I don't understand all the negativity

    The phase 2 studies on nx-1207 are favorable, and the comments of several urologists are also quite favorable. The drug is being compared to a placebo, which sets a low bar. I remain optimistic that the drug will prove quite superior to the placebo injection. The safety studies have also uniformly been favorable. I am optimistic for an easy FDA approval

    Sentiment: Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Nothing is easy regarding FDA. I do believe that the explanation for combining studies makes since. It is not clear why the initial division with so many similarities. Generally takes 700-1000 for approval. For the time we have waited this release clearly will be it. Again if it was bad enough they would have probably been forced to stop the study. The organization of the data along with analysis being conducted by private company probably dictating release to maximize public reaction. As usual lots of pertinent negatives and perceptions remain. I have enough tied up in this dog to be nervous, but continue to see a phase 3study with progress albeit slow

 
NYMX
1.3529-0.0371(-2.67%)11:52 AMEDT